Skip to content

Comparison between dexmedetomidine & clonidine as adjuvant to 1% chloroprocaine in spinal anaesthesia for below umbilicus surgeries

A comparative study of dexmedetomidine and clonidine as adjuvant to intrathecal 1 % chloroprocaine in patients undergoing infra umbilical surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037587
Enrollment
86
Registered
2021-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: NIL: NIL Control Intervention1: Not applicable: Not applicable Control Intervention2: Dexmedetomidine: Dexmedetomidine is selective alpha-2 agonist used intrathecal for subarachnoid blo

Sponsors

Vijayanagar institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA 1 to 2 Patients undergoing elective infra umbilical surgeries

Exclusion criteria

Exclusion criteria: Patient refusal for spinal anaesthesia History of allergy to study drugs Any contra indication for spinal anaesthesia Deformity of lumbosacral spine

Design outcomes

Primary

MeasureTime frame
Compare the time taken for two segment regression of sensory blockade between the two groupsTimepoint: from intrathecal injection of drug to two segment regression of maximal dermatomal achieved

Secondary

MeasureTime frame
Onset of sensory blockade Onset of motor blockade Duration of sensory blockade Duration of motor blockade Intra and immediate postoperative hemodynamics Duration of analgesia Need for the first rescue analgesiaTimepoint: Intra and post operative

Countries

India

Contacts

Public ContactDR BALA SUBRAMANYA H

Vijayanagar institute of medical sciences, Ballari

amitghale4@gmail.com9686988369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026